Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays

HIGHLIGHTS

• who: Kristina Schwamborn et al. from the Institute of Pathology, Technische Universität München, Trogerstr18, Munich, Germany have published the paper: Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays, in the Journal: (JOURNAL)
• what: The aim was to assess the overall technical comparability of the four assays in terms of percentage of PDL1-stained IC, adjusted for reader effects. Model, adjusted mean percentages were obtained for each assay, with 95% confidence intervals for means . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.